Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...

As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

The scenario is common. An elderly person seems to be in good health until one day they suffer a fall, and from then on their ...

Read this article to learn how the introduction of a health promotion role increased onward referrals to smoking cessation ...

Organ transplantation is a medical marvel that saves lives and offers renewed hope to patients suffering from chronic ...